CTLA4 and neoplasm: Mechanistically, this combination treatment with non-ablative radiation therapy and CTLA4 blockade led to increased density of tumor-infiltrating lymphocytes, increased CD8/CD4 ratio, and broadening of the TCR repertoire (36).